Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Dow
Cerilliant
Moodys
Express Scripts
Harvard Business School
Citi
Julphar
Teva
Johnson and Johnson

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 9,114,168

« Back to Dashboard

Which drugs does patent 9,114,168 protect, and when does it expire?

Patent 9,114,168 protects MOXEZA and is included in one NDA.

This patent has twenty-one patent family members in thirteen countries.
Summary for Patent: 9,114,168
Title:Pharmaceutical compositions containing a fluoroquinolone antibiotic drug
Abstract: Pharmaceutical compositions containing a fluoroquinolone antibiotic drug are disclosed. The compositions exhibit improved homogeneity, improved bioavailability, lower turbidity or a combination thereof. The composition can be use as otic or nasal compositions, but are particularly useful as ophthalmic compositions.
Inventor(s): Campins; Inmaculada (Mataro, ES), Jimenez; Nuria (Barcelona, ES), Vidal; Roman (Vallromanes, ES), Carreras; Nuria (Caldes de Montbui, ES), Martinez; Carmen (Llicade Vall, ES), Galan; Francisco Javier (Teia, ES)
Assignee: Alcon Pharmacueticals Ltd. (Fribourg, CH)
Application Number:13/745,062
Patent Claim Types:
see list of patent claims
Composition; Dosage form;

Drugs Protected by US Patent 9,114,168

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Novartis Pharms Corp MOXEZA moxifloxacin hydrochloride SOLUTION/DROPS;OPHTHALMIC 022428-001 Nov 19, 2010 AT2 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 9,114,168

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,450,311 Pharmaceutical compositions containing a fluoroquinolone antibiotic drug ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 9,114,168

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 104814961 ➤ Try a Free Trial
European Patent Office 2299974 ➤ Try a Free Trial
Japan 2011522823 ➤ Try a Free Trial
Japan 5509201 ➤ Try a Free Trial
South Korea 20110039219 ➤ Try a Free Trial
South Korea 101587056 ➤ Try a Free Trial
Russian Federation 2494727 ➤ Try a Free Trial
Mexico 2010012933 ➤ Try a Free Trial
Russian Federation 2010154545 ➤ Try a Free Trial
China 102056590 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Fish and Richardson
Chubb
US Department of Justice
Julphar
UBS
US Army
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot